HOW PATIENTS PREVENT AND RECOVER SPEEDIER FROM COVID-19 USING THESE PROTOCOLS
Ivermectin, an anti-parasitic medicine whose discovery won the Nobel Prize in 2015, has proven, highly potent, anti-viral and anti-inflammatory properties in laboratory studies. In the past 4 months, numerous, controlled clinical trials from multiple centers and countries worldwide are reporting consistent, large improvements in COVID-19 patient outcomes when treated with Ivermectin.
William C. Campbell delivered his Nobel Lecture on 7 December 2015 at Aula Medica, Karolinska Institutet in Stockholm.
This lecture raises a major question, the ways science abandoned the trusted methodology of clinical studies in favour of complex statistical studies . This is what has allowed the use of repurposed medecines for Covid19 ( Ivermectin, HCQ) to be dismissed as “unscientific”.